Related Experiment Videos
Lamivudine for chronic hepatitis B: the magic bullet or just another bright prospect?
Gastroenterology
|May 29, 1999
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
Alimentary pharmacology & therapeutics·2018
Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.
Alimentary pharmacology & therapeutics·2017
Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.
Alimentary pharmacology & therapeutics·2016
Real-world effectiveness for 12 weeks of ledipasvir-sofosbuvir for genotype 1 hepatitis C: the Trio Health study.
Journal of viral hepatitis·2016
Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies.
Minerva gastroenterologica e dietologica·2015
A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease.
Alimentary pharmacology & therapeutics·2015
Progress in Synthesis and Pharmacology of Telmisartan.
Chemistry & biodiversity·2026
Functional psychosurgery in psychiatry: indications and preoperative evaluation. A narrative review.
Frontiers in psychiatry·2026
Development of humanized mouse models for the preclinical evaluation of NK cell-based therapies.
Frontiers in immunology·2026